Formulation for the Delivery of Nucleotide Sequences That Can Modulate Endogenous Interfering RNA Mechanisms

Identification and use of target genes for control of plant parasitic nematodes

Methods for treating and/or limiting development of diabetes

METHODS AND COMPOSITIONS FOR CONTROLLING ASSEMBLY OF VIRAL PROTEINS

BIODEGRADABLE POLYMERIC BUFFERS

Multicomponent degradable cationic polymers

Compositions and methods for treating pruritus

Method for the treatment of cardiovascular fibrosis

Piggy back delivery of nucleic acids into organisms

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

Biotin complexes for treatment and diagnosis of alzheimer's disease

Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides

LYVE-1 ANTAGONISTS FOR PREVENTING OR TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH LYMPHANGIOGENESIS

Combined treatment with netrin-1 interfering drug and chemotherapeutic drug

Sorafenib-microRNA combination therapy for liver cancer

METHOD OF USING SEQUENCE OF ANTAGOMIR FOR DEVELOPING MEDICINE FOR INHIBITING ORAL CANCER CELLS FROM SPREADING

CANCER MARKER AND THE USE THEREOF

THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE

Methods for producing a population of pancreatic beta-cells

Use of miR-494 to modulate TRAIL-induced apoptosis through BIM down-regulation

THERAPY FOR DRUG RESISTANT CANCER

Methods and compositions for treating cancer

Polynucleotides having bioreversible groups

ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES

TELOMERASE INHIBITORS FOR USE IN THERAPY

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

Methods for sustained and regulatable gene expression using viral based expression vectors

Amphoteric liposomes

Veterinary composition and methods for non-surgical neutering and castration

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

Methods and compositions using miR-3151 in the diagnosis and treatment of cancer

Method for regulating cell proliferation

Pharmaceutical composition and uses thereof

Compositions and methods for treating fibrotic disease

METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY

TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1

INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX

ENDO180-TARGETED PARTICLES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Compositions for the delivery of RNA and drugs into cells

GALECTIN-3 INHIBITOR (GAL-3M) IS ASSOCIATED WITH ADDITIVE ANTI-MYELOMA AND ANTI-SOLID TUMOR EFFECTS, DECREASED OSTEOCLASTOGENESIS AND ORGAN PROTECTION WHEN USED IN COMBINATION WITH PROTEASOME INHIBITORS

METHODS AND COMPOSITIONS FOR INHIBITING A MULTI-CANCER MESENCHYMAL TRANSITION MECHANISM

CELL-SPECIFIC DELIVERY OF MIRNA MODULATORS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS

Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers

INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY

DELIVERY OF SMALL INTERFERING RNA AND MICRO RNA THROUGH MEMBRANE-DISRUPTIVE, RESPONSIVE NANOSCALLE HYDROGELS

Compositions and methods for detecting and treating colorectal cancer

Diagnosis and treatment of brain tumor

COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES

Compositions and methods for modifying a predetermined target nucleic acid sequence

MicroRNA-198 as a tumor suppressor in ovarian cancer

Therapeutic method for pancreatic cancer

Molecular sleds and uses thereof

Agent for treating or inhibiting recurrence of acute myeloid leukemia

Anandamide-modified nucleic acid molecules

CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE

MicroRNA-based approach to treating malignant pleural mesothelioma

ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors

Combination Therapy III

Core-shell particle formulation for delivering multiple therapeutic agents

CTLA-4 aptamer siRNA species

CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION

Nucleic acid complexes

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Methods relating to DNA-sensing pathway related conditions

Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA

EpCAM aptamer for detection of cancer stem cells

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents

Nucleic acid complexes

Methods and compositions for treating prostate cancer

COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROINJURY AND METHODS OF USE THEREOF

Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability

Ligand-conjugated monomers

WOUND HEALING

Methods of treating metabolic disease

ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES

Method to treat or prevent herpesvirus infections

ANTISENSE MODULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION

Diagnostic and screening methods for atopic dermatitis

Antisense Oligonucleotides Against Neutral Sphingomyelinase and Neutral Sphingomyelinase Inhibitor GW4869 for Degenerative Neurological Disorders

Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation

COMPOSITIONS AND METHODS FOR SELECTIVELY PRODUCING SIRNA

Methods of identifying and treating glioblastoma

H4 receptor inhibitors for treating tinnitus

HIGH-THROUGHPUT SYNTHESIS OF NANOPARTICLES

Cationic lipid

Compositions And Methods For Modulating Pro-Inflammatory Immune Response

Methods and Compositions for Modulating Beta Cell Proliferation

Compositions and methods for treating alzheimer's disease and other tauopathies

Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity

Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG

METHODS FOR TREATING MDS1-EVI1 MEDIATED CANCER

TIKI inhibitors

METHODS AND COMPOSITIONS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR-1alpha (PGC1alpha) AS A TARGET OF CIRCULATING TUMOR CELLS

Low density lipoprotein receptor-mediated siRNA delivery

Therapeutic calcium phosphate nanoparticle incorporating siRNA useful in treating disease

Compositions and methods for controlling arthropod parasite and pest infestations

Polycarbonates bearing aromatic N-heterocycles for drug delivery

Treatments of oxidative stress conditions

Method for treatment of castration-resistant prostate cancer

Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA

Compounds and methods for altering RSV replication rate

Methods of treating vascular inflammatory disorders

Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity

THERAPIES FOR CANCER USING RLIP76

METHODS AND COMPOSITIONS OF MODULATING TUMOR INITIATING CELLS AND THE USE THEREOF

Isoform of Bruton's Tyrosine Kinase (BTK) Protein

METHODS AND PRODUCTS RELATED TO LUNG CANCER

Modified small interfering RNA molecules and methods of use

Methods and compositions for inhibiting the growth and/or proliferation of MYC-driven tumor cells

EGFR antagonist for the treatment of heart disease

THERAPEUTIC METHODS FOR PERITONEAL CARCINOMATOSIS

Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer

Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury

Methods, Compositions and Drug Delivery Systems for Intraocular Delivery of siRNA Molecules

Sustained release siRNA for ocular drug delivery

Lipidated glycosaminoglycan particles for the delivery of nucleic acids

Therapeutic micro RNA targets in chronic pulmonary diseases

Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections

Compositions for controlling mites in bees

REGULATION OF CARDIAC SODIUM CHANNELS BY SIRT1 AND SIRT1 ACTIVATORS

Compositions and methods for inducing myoblast differentiation and myotube formation

Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes

METHODS OF MODULATING ANGIOGENESIS VIA TRPV4

Materials and methods related to MicroRNA-21, mismatch repair, and colorectal cancer

Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors

Combination Treatment of Multiple Myeloma

Methods and compositions for the treatment of insulin-associated medical conditions

Liposome and method for producing liposome

Carbohydrate conjugates as delivery agents for oligonucleotides

Carbohydrate conjugates as delivery agents for oligonucleotides

Lipid nanoparticle compositions and methods of making and methods of using the same

Formulations for the delivery of active ingredients

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

Modulator compounds of drug resistance in epithelial tumor cells

Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage

Compositions and methods for silencing ebola virus gene expression

Compositions and methods for inhibiting expression of the ALAS1 gene

Cancer therapeutics

ANTIMICROBIAL POLYNUCLEOTIDE-TEMPLATED METAL NANOCLUSTER

Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

Fidgetin-like 2 as a target to enhance wound healing

Compositions and methods for modulating circadian synchronization

Use of CDK9 inhibitors to reduce cartilage degradation

Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

GNAQ targeted dsRNA compositions and methods for inhibiting expression

USE OF RNA INTERFEARENCE, FARNESOIC ACID AND RECOMBINANT PROTEIN APPROACH TO INDUCE GONAD MATURATION IN CRUSTACEAN SPECIES

High drug loading system to co-deliver anticancer drugs and nucleic acids for cancer therapy

Polyamine derivatives

Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family

Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)

Prophylactic or therapeutic agent for hepatic diseases

Block copolymer, liquid composite thereof, nucleic acid preparation, preparation methods therefor, and use thereof

Targeted and modular exosome loading system

Micro-RNAs involved in macular degeneration

G protein-coupled purinergic receptor Gpr17 mediates orexigenic effects of FoxO1 in AgRP neurons

COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF siRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES

MICRORNA COMPOSITIONS AND METHODS

Peptide-conjugated oligonucleotide therapeutic and method of making and using same

Individualized cancer therapy

Liposome structures and methods of use thereof

Use of survivin antagonists in polyomavirus-related disease

RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE

Compositions containing resveratrol and nucleotides

Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3

Unit structure-type pharmaceutical composition for nucleic acid delivery

Targeting micrornas for the treatment of fibrosis

Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases

Medicament for treatment of liver cancer

MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE

Agents and methods for treating and preventing seborrheic keratosis

Polymeric nanocarriers with linear dual response mechanism

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

Methods and pharmaceutical compositions for the treatment of hypertension

BIOMARKERS FOR CANCER CHARACTERIZATION AND TREATMENT

RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor

Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD

METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM

Glycoconjugates of RNA interference agents

METHOD FOR ENHANCING EFFICACY AND SELECTIVITY OF CANCER CELL KILLING BY DNA DAMAGING AGENTS

Trialkyl cationic lipids and methods of use thereof

Antisense conjugates for decreasing expression of DMPK

Double-stranded oligonucleotides

Methods for the treatment of nonalcoholic steatohepatitis

Cellular targets for HIV infection

Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment

Magnetic nanoparticle-samirna complex and method for preparing same

Block copolymer having phenylboronic acid group introduced therein, and use thereof

Reverse micelle system comprising nucleic acids and use thereof

Methods and compositions for RNAi-based cancer treatment

Lipids and compositions for intracellular delivery of biologically active compounds

Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3

Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase inhibitors or anti-folates

Delivery of dsRNA to arthropods

Methods and Compositions for Gene Delivery

Nucleic acids encoding anti-Siglec-15 antibodies

METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND OTHER DEMYELINATING DISORDERS

FAS-chimera adenovirus vector

CYCLON EXPRESSION FOR THE IDENTIFICATION AND CONTROL OF CANCER CELLS

Compositions for Inhibiting Gene Expression and Uses Thereof

Gelatin-based nanoparticle complex for tumor-targeted delivery of siRNA and method for preparing the same

Modified L-nucleic Acid

Extended dicer substrate agents and methods for the specific inhibition of gene expression

Extended dicer substrate agents and methods for the specific inhibition of gene expression

Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1

Pharmaceutical composition for preventing or treating diabetes containing TENC1 expression or activity suppressor

Nano delivery systems for siRNA

siRNA compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer

NOVEL THERAPEUTIC TARGET FOR THE PREVENTION OF TUMOUR METASTASIS

ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2

METHODS OF INDUCING TISSUE REGENERATION

Methods to regulate polarization and enhance function of cells

Coated lipid complexes and their use

Methods and compositions for neuroprotection

Self-assembled nanostructures

COMPOSITIONS AND METHODS FOR TREATING UNDERACTIVE BLADDER

Increasing taxane sensitivity in cancer cells

POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF

Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders

P2X7, Inhibition Of Epithelial Cancers And Papillomas

Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro

Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase

Methods of treating urothelial carcinoma

Treatment of disease by modulation of SIRT6

Methods for Treating or Preventing Ophthalmological Conditions

Carbohydrate conjugates as delivery agents for oligonucleotides

RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF

Method for enhancing remyelination using GLI1 inhibitors

Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier

Methods, kits, and systems for treatment of metastatic papillary thyroid cancer

Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin

COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS

Induced pluripotent stem cell model of chronic myeloid leukemia revealed olfactomedin 4 as a novel therapeutic target in leukemia stem cells

Methods and compositions involving miRNA and miRNA inhibitor molecules

Glycogen-based cationic polymers

Collateral gene inactivation biomarkers and targets for cancer therapy

METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS

Stabilization of biomolecules using sugar polymers

Compositions and methods for delivering inhibitory oligonucleotides

NOVEL OLIGONUCLEOTIDE CONJUGATES AND USE THEREOF

Pharmaceutical composition for treating cancer

Amine cationic lipids and uses thereof

Method for the controlled intracellular delivery of nucleic acids

Method for identifying bromodomain inhibitors

Therapeutic nanoparticles and methods of use thereof

Pharmaceutical composition for a foaming eye drop

Methods for the treatment of hepatitis B and hepatitis D infections

Methods for the treatment of hepatitis B and hepatitis D infections

Methods and compositions for the treatment of cancer

LIPID NANOPARTICLES FOR TARGETED siRNA DELIVERY

MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES

RNAi-mediated inhibition of tumor necrosis factor α-related conditions

Pharmaceutical compositions comprising small interfering RNA inhibitors of NOX3

Targeted Crosslinked Multilamellar Liposomes

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

Combination therapy to prevent DCIS formation and progression to breast cancer

COMPOSITIONS AND METHODS FOR TREATMENT OF METASTATIC CANCER

Method for inhibiting influenza virus infection

Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro

Peptide sequence design and use thereof for peptide-mediated siRNA delivery

Extended dicer substrate agents and methods for the specific inhibition of gene expression

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity

Serapina1 iRNA compositions and methods of use thereof

Particles comprising single stranded RNA and double stranded RNA for immunomodulation

Polymeric Drug-Delivery Material, Method For Manufacturing Thereof And Method For Delivery Of A Drug-Delivery Composition

COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA

HE4 based therapy for malignant disease

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

Oligonucleotides for RNA interference and biological applications thereof

METHODS AND COMPOSITIONS FOR REDUCING ACTIVITY OF THE ATRIAL NATRIURETIC PEPTIDE RECEPTOR AND FOR TREATMENT OF DISEASES

Methods of treating age related disorders

Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

Method of treating hyperlipidemia and atherosclerosis with miR-30C

Compositions and methods for the diagnosis and therapy of BCL2-associated cancers

METHODS AND FORMULATIONS TO ACHIEVE TUMOR TARGETED DOUBLE STRANDED RNA MEDIATED CELL DEATH

Methods and pharmaceutical compositions for treating cancer

CNS targeting AAV vectors and methods of use thereof

Lipids, lipid complexes and use thereof

1,3,5-triazinane-2,4,6-trione derivatives and uses thereof

SELF DELIVERING BIO-LABILE PHOSPHATE PROTECTED PRO-OLIGOS FOR OLIGONUCLEOTIDE BASED THERAPEUTICS AND MEDIATING RNA INTERFERENCE

NUCLEIC ACID PARTICLES, METHODS AND USE THEREOF

Methods for stimulating hematopoietic recovery by inhibiting TGFβ signaling

Lin28-mediated control of let-7 biogenesis

MARKER AND TARGET FOR RESPONSIVENESS AND RESISTANCE TO CANCER AGENTS

Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease

METHODS AND COMPOSITIONS FOR TREATING DISEASES, DISORDERS OR INJURY OF THE NERVOUS SYSTEM

Amino alcohol cationic lipids for oligonucleotide delivery

PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition

Alpha-aminoamidine polymers and uses thereof

Osteoprotegerin in neuroprotection

Methods for treating obesity

Methods and compositions for the specific inhibition of met by double stranded RNA

Methods for treating chronic pain